Earnings Estimate Revisions

Search documents
Earnings Estimates Rising for Columbia Financial (CLBK): Will It Gain?
ZACKS· 2025-08-25 17:21
Core Viewpoint - Columbia Financial (CLBK) is positioned as a strong investment opportunity due to its improving earnings outlook and positive analyst sentiment, which is reflected in rising earnings estimates [1][2]. Earnings Estimate Revisions - The trend in earnings estimate revisions indicates growing analyst optimism, which is expected to positively impact the stock price [2]. - For the current quarter, Columbia Financial is projected to earn $0.13 per share, representing a significant increase of +116.7% from the previous year [6]. - Over the last 30 days, the Zacks Consensus Estimate for the current quarter has risen by 13.04%, with two estimates moving higher and no negative revisions [6]. - For the full year, the earnings estimate is $0.48 per share, reflecting a change of +108.7% from the prior year [7]. - The consensus estimate for the current year has increased by 9.09% over the past month, with two estimates moving higher and no negative revisions [7][8]. Zacks Rank and Performance - Columbia Financial has achieved a Zacks Rank 2 (Buy), indicating favorable conditions for investment based on the positive estimate revisions [9]. - The Zacks Rank system has a strong track record, with Zacks 1 (Strong Buy) stocks averaging an annual return of +25% since 2008 [3]. - Stocks with Zacks Rank 1 and 2 are shown to significantly outperform the S&P 500 [9]. Stock Performance - The stock has gained 9.1% over the past four weeks, driven by solid estimate revisions and positive earnings growth prospects [10].
Can Rush Street Interactive (RSI) Run Higher on Rising Earnings Estimates?
ZACKS· 2025-08-25 17:21
Rush Street Interactive, Inc. (RSI) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-t ...
Earnings Estimates Rising for Pagaya Technologies Ltd. (PGY): Will It Gain?
ZACKS· 2025-08-25 17:21
Pagaya Technologies Ltd. (PGY) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate ...
Will Farmers National (FMNB) Gain on Rising Earnings Estimates?
ZACKS· 2025-08-25 17:20
Core Viewpoint - Farmers National Banc (FMNB) is experiencing solid improvement in earnings estimates, which is likely to continue driving its stock price momentum [1][2] Earnings Estimate Revisions - Analysts have shown growing optimism regarding FMNB's earnings prospects, leading to a rising trend in estimate revisions that should positively impact the stock price [2] - For the current quarter, FMNB is expected to earn $0.41 per share, reflecting a year-over-year increase of +78.3% and a 12.5% increase in consensus estimates over the last 30 days [6] - For the full year, the expected earnings per share is $1.59, indicating a year-over-year change of +24.2%, with a 6.71% increase in consensus estimates due to positive revisions [7][8] Zacks Rank and Performance - FMNB has achieved a Zacks Rank 2 (Buy), indicating strong agreement among analysts in raising earnings estimates, which historically correlates with stock outperformance [9] - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have shown significant outperformance compared to the S&P 500 [9] Stock Performance - The stock has gained 10.3% over the past four weeks, driven by solid estimate revisions and positive earnings growth prospects [10]
Why Middlefield Banc (MBCN) Might be Well Poised for a Surge
ZACKS· 2025-08-25 17:20
Middlefield Banc Corp. (MBCN) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term st ...
Why Carter Bankshares (CARE) Might be Well Poised for a Surge
ZACKS· 2025-08-25 17:20
Core Viewpoint - Carter Bankshares, Inc. (CARE) is showing solid improvement in earnings estimates, which may lead to continued stock price momentum [1][2]. Earnings Estimate Revisions - Analysts are increasingly optimistic about Carter Bankshares' earnings prospects, as reflected in the upward trend of estimate revisions [2][3]. - The current quarter's earnings estimate is projected at $0.39 per share, indicating a year-over-year increase of +69.6% [5]. - The Zacks Consensus Estimate for the current quarter has risen by 14.71% over the last 30 days, with two estimates increasing and no negative revisions [5]. - For the full year, the earnings estimate stands at $1.50 per share, representing a +42.9% change from the previous year [6]. - The consensus estimate for the current year has increased by 15.39% due to two upward revisions and no negative changes [7]. Zacks Rank and Performance - Carter Bankshares currently holds a Zacks Rank 2 (Buy), indicating favorable conditions for investment based on earnings estimate revisions [8]. - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [8]. Investment Outlook - The stock has appreciated by 7.5% over the past four weeks due to strong estimate revisions, suggesting potential for further upside [9].
Earnings Estimates Rising for United Bankshares (UBSI): Will It Gain?
ZACKS· 2025-08-25 17:20
Core Viewpoint - United Bankshares (UBSI) is experiencing solid improvement in earnings estimates, which is likely to positively impact its stock price [1][2]. Earnings Estimates - Analysts are increasingly optimistic about the earnings prospects for United Bankshares, leading to higher earnings estimates that should reflect in the stock price [2]. - The current quarter's earnings estimate is $0.82 per share, representing a 17.1% increase from the previous year [6]. - For the full year, the expected earnings are $3.14 per share, indicating a 14.2% increase from the prior year [7]. Estimate Revisions - Over the past 30 days, the Zacks Consensus Estimate for the current quarter has risen by 5.58%, with three estimates moving higher and no negative revisions [6]. - The consensus estimate for the full year has increased by 5.86%, with four estimates revised upward and no negative revisions [8]. Zacks Rank - United Bankshares currently holds a Zacks Rank 2 (Buy), reflecting strong agreement among analysts in revising earnings estimates upward [9]. - Stocks with Zacks Rank 1 (Strong Buy) and 2 (Buy) have historically outperformed the S&P 500 [9]. Stock Performance - United Bankshares shares have increased by 7% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [10].
Earnings Estimates Rising for Helios Technologies (HLIO): Will It Gain?
ZACKS· 2025-08-25 17:20
Core Viewpoint - Helios Technologies (HLIO) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise their earnings estimates [1][2]. Earnings Estimate Revisions - The upward trend in earnings estimate revisions reflects growing optimism among analysts regarding Helios Technologies' earnings prospects, which is expected to positively impact its stock price [2]. - The current-quarter earnings estimate is projected at $0.64 per share, indicating a year-over-year increase of +8.5%, with a 28% rise in the Zacks Consensus Estimate over the last 30 days [6]. - For the full year, the earnings estimate stands at $2.40 per share, representing a +14.3% change from the previous year, with a 26.32% increase in the consensus estimate during the same period [7][8]. Zacks Rank and Performance - Helios Technologies has achieved a Zacks Rank 1 (Strong Buy) due to strong agreement among analysts in revising earnings estimates upward, which historically correlates with stock price performance [3][9]. - Stocks with a Zacks Rank 1 and 2 (Buy) have shown significant outperformance compared to the S&P 500 [9]. Recent Stock Performance - Helios Technologies shares have increased by 42% over the past four weeks, indicating investor confidence in the company's earnings growth prospects [10].
Experian (EXPGY) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-08-25 17:01
Investors might want to bet on Experian PLC (EXPGY) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings p ...
Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock?
ZACKS· 2025-08-25 17:01
Core Viewpoint - Guardian Pharmacy Services (GRDN) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [2][4]. - Institutional investors often rely on earnings estimates to determine a company's fair value, leading to buying or selling actions that affect stock prices [4]. Business Outlook and Investor Sentiment - The upgrade in earnings estimates for Guardian Pharmacy suggests an improvement in the company's underlying business, which could lead to increased stock prices as investors respond positively [5][10]. - The Zacks Consensus Estimate for Guardian Pharmacy has increased by 4.1% over the past three months, with expected earnings of $0.93 per share for the fiscal year ending December 2025, indicating stability year-over-year [8]. Zacks Rank System - The Zacks Rank system categorizes stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7]. - Guardian Pharmacy's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].